Seoulin Bioscience Co.,Ltd. (KOSDAQ:038070)
South Korea flag South Korea · Delayed Price · Currency is KRW
6,590.00
-140.00 (-2.08%)
Last updated: Mar 24, 2025

Seoulin Bioscience Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Net Income
2,914-117.5510,15915,5894,893
Upgrade
Depreciation & Amortization
1,3651,2871,0171,9301,984
Upgrade
Loss (Gain) From Sale of Assets
65.1131.420.65-14,092-0.27
Upgrade
Asset Writedown & Restructuring Costs
152.6-393.031,044-
Upgrade
Loss (Gain) From Sale of Investments
-1,9864,966-2,011-160.11-118.2
Upgrade
Loss (Gain) on Equity Investments
-139.95-85.1-84.76-114.5-89.12
Upgrade
Provision & Write-off of Bad Debts
328.55-61.68452.7727.35-104.66
Upgrade
Other Operating Activities
424.551,869-4,1635,535-1,107
Upgrade
Change in Accounts Receivable
5,504-6,2693,048-1,314-489.6
Upgrade
Change in Inventory
-4,345-7,528-3,918-3,025220.75
Upgrade
Change in Accounts Payable
-6,4472,936-2,1634,435-1,830
Upgrade
Change in Other Net Operating Assets
-2,4473,903-7,086-938.58326.52
Upgrade
Operating Cash Flow
-4,611930.57-4,3568,9183,684
Upgrade
Operating Cash Flow Growth
---142.03%-49.67%
Upgrade
Capital Expenditures
-48.45-945.51-461.62-933.29-401.34
Upgrade
Sale of Property, Plant & Equipment
0.49123.7559.8620,41813.26
Upgrade
Cash Acquisitions
---35.23--
Upgrade
Divestitures
0.08----
Upgrade
Sale (Purchase) of Intangibles
-13.97--245.42-669.69-541.34
Upgrade
Investment in Securities
6,42928,576-1,904-49,9341,608
Upgrade
Other Investing Activities
-12.68-204.53-44.07-312.189.21
Upgrade
Investing Cash Flow
6,38927,526-2,665-31,499708.85
Upgrade
Short-Term Debt Issued
3,000550.555.95125.7315.7
Upgrade
Long-Term Debt Issued
-0.13-30,000500
Upgrade
Total Debt Issued
3,000550.6355.9530,126515.7
Upgrade
Short-Term Debt Repaid
-50-40.18-35.27-38.5-11
Upgrade
Long-Term Debt Repaid
-8,475-22,083-296.05-229.77-16.93
Upgrade
Total Debt Repaid
-8,525-22,123-331.32-268.27-27.93
Upgrade
Net Debt Issued (Repaid)
-5,525-21,573-275.3729,857487.77
Upgrade
Repurchase of Common Stock
-1,092-142.62-198.94-80.6-168.98
Upgrade
Dividends Paid
-836.16-1,062-798.49-769.16-721.15
Upgrade
Other Financing Activities
--02,350-0-
Upgrade
Financing Cash Flow
-7,453-22,7781,07729,008-402.37
Upgrade
Foreign Exchange Rate Adjustments
22.54-75.93-30.247.83-35.7
Upgrade
Miscellaneous Cash Flow Adjustments
0--000
Upgrade
Net Cash Flow
-5,6535,603-5,9746,4753,955
Upgrade
Free Cash Flow
-4,660-14.95-4,8177,9843,283
Upgrade
Free Cash Flow Growth
---143.19%-53.44%
Upgrade
Free Cash Flow Margin
-6.18%-0.02%-4.60%9.91%5.04%
Upgrade
Free Cash Flow Per Share
-534.60-1.71-442.90908.19373.19
Upgrade
Cash Interest Paid
48.2520.7910.8314.2318.66
Upgrade
Cash Income Tax Paid
1,2951,4085,837668.252,634
Upgrade
Levered Free Cash Flow
-8,710-12,310-12,85327,5271,586
Upgrade
Unlevered Free Cash Flow
-8,504-10,759-11,42427,6671,597
Upgrade
Change in Net Working Capital
10,40212,65917,482-22,6832,238
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.